Deepcure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists, and biologists. Using an end-to-end drug discovery platform and automated robotic wet lab, the Company is developing a novel pipeline of precision small molecules across many different therapeutic indications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/08/21 | $40,000,000 | Series A |
Benon Group Morningside Venture  Sapir Venture Partners TLV Partners | undisclosed |
| 04/11/24 | $24,600,000 | Series A-1 |
Benon Group IAG Capital Partners Morningside Venture Sapir Venture Partners TLV Partners | undisclosed |
